These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Therapy of thromboses with low-molecular-weight heparins]. Haas S; Haas P Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321 [TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism. Pineo GF; Hull RD Annu Rev Med; 1997; 48():79-91. PubMed ID: 9046947 [TBL] [Abstract][Full Text] [Related]
7. [Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home]. Osterkorn D; Schramm W; Szucs T Med Klin (Munich); 1996 Sep; 91(9):607-9. PubMed ID: 8984321 [TBL] [Abstract][Full Text] [Related]
8. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis. Penner J N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247 [No Abstract] [Full Text] [Related]
9. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis. Strandness DE N Engl J Med; 1996 Aug; 335(9):670-1; author reply 671-2. PubMed ID: 8692246 [No Abstract] [Full Text] [Related]
10. [Standard heparin versus low-molecular-weight heparin]. Lockner D Wien Med Wochenschr; 1999; 149(2-4):37-8. PubMed ID: 10378320 [TBL] [Abstract][Full Text] [Related]
11. Effects of standard unfractionated and low-molecular-weight heparins on platelets of patients undergoing total hip replacement surgery. Aulmann M; Kwasniki S; Böttiger BW; Meeder PJ Beitr Infusionsther Transfusionsmed; 1997; 34():242-7. PubMed ID: 9356680 [TBL] [Abstract][Full Text] [Related]
15. [Monitoring blood coagulation]. Pabinger-Fasching I Wien Med Wochenschr; 1999; 149(2-4):70-1. PubMed ID: 10378328 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review]. Lamy O; Cornuz J; Yersin B Schweiz Med Wochenschr; 1999 May; 129(18):707-14. PubMed ID: 10407944 [TBL] [Abstract][Full Text] [Related]
18. Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH). Samama MM Adv Exp Med Biol; 1992; 313():275-81. PubMed ID: 1332441 [No Abstract] [Full Text] [Related]
19. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study. Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543 [TBL] [Abstract][Full Text] [Related]
20. Comparative studies on properties of unfractionated and low molecular weight heparin. Sakuragawa N; Takahashi K Semin Thromb Hemost; 1990 Oct; 16 Suppl():5-11. PubMed ID: 1962905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]